Exceptional Financial Performance
Transaction value grew by more than 150% and adjusted EBITDA grew by over 200% year-over-year in 2024. The company delivered record fourth-quarter results across all key performance metrics.
Strength in P&C Insurance Vertical
P&C transaction value was up sequentially and above normal seasonality due to higher year-over-year pricing and volumes. P&C transaction value is expected to grow approximately 170% year-over-year in Q1 2025.
Positive Long-term Outlook for Medicare Advantage
Despite near-term pressures, the Medicare Advantage market, a several $100 billion industry, is at a nascent stage of online advertising adoption, presenting a significant long-term growth opportunity.
Deleveraging and Strong Cash Position
The company ended the quarter with $43 million of cash and a net debt to 2024 adjusted EBITDA of less than 1.3 times, indicating solid progress in deleveraging.
Guidance for Q1 2025
Q1 transaction value is expected to be between $415 million and $440 million, revenue between $225 million and $245 million, and adjusted EBITDA between $24.5 million and $26.5 million, all showing significant year-over-year growth.